Vicky Cory

Just Keep Smiling.

[KCTV5 News @KCTV5]

The Kansas Department of Health and Environment issued an Air Quality Health Advisory on March 14 due to extreme winds pushing dust and smoke throughout the state. https://t.co/zFm4aaKoLJ

[Vicky Cory @VCory]

(1) New Messages! https://t.co/4htNmwosNE

[Vicky Cory @VCory]

Exceeding Budgets & Falling Short: EVERSANA Leaders Tell Hard Truths About Omnichannel - https://t.co/Dki27TLDUU

[Vicky Cory @VCory]

Onwards & Upwards - The Conundrums Live Performance https://t.co/dKicnzGGLd via @YouTube

[Vicky Cory @VCory]

@VenmoSupport I closed and reopened the app. Still getting an error and it won't let me send money.

[EVERSANA INTOUCH @EVERSANAINTOUCH]

Being named a 2022 PM360 Trailblazer Advertising Agency CEO of the Year is just one of many reasons we’re proud to have @farukcapan as our fearless leader. Congrats on the well-deserved recognition! https://t.co/NQnjvc0ZTN #PM360Trailblazers

[Vicky Cory @VCory]

Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at ENDO 2022, the Endocrine Society’s Annual Meeting https://t.co/yKrAU7phjf

[Vicky Cory @VCory]

@MrsKimmel5th @hnhuskies Congrats Viv!!

[Vicky Cory @VCory]

Clarus Therapeutics Announces Issuance of Patent Covering JATENZO® (testosterone undecanoate) https://t.co/Na4sFFwmxa

[Vicky Cory @VCory]

Clarus Therapeutics to Report First Quarter 2022 Financial and Operating Results https://t.co/qHNmSR7IP2

[Vicky Cory @VCory]

Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering CLAR-121 (Testosterone + Anastrozole) for Treatment of Androgen-Mediated Autoimmune Inflammatory Mastitis https://t.co/DMKAuwAfrm

[Vicky Cory @VCory]

Exciting pipeline news for team Clarus!

[Vicky Cory @VCory]

Clarus Therapeutics Announces Pricing of Upsized $30.0 Million Underwritten Public Offering https://t.co/KT2YTZd2rS

[Vicky Cory @VCory]

Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at the Androgen Society 4th Annual Meeting https://t.co/sHDlg1Xt8w

[Vicky Cory @VCory]

Clarus Announces Initiation of Phase 4 Clinical Trial of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadal Men with Chronic Kidney Disease https://t.co/Oc3hceXkzX

[Vicky Cory @VCory]

Go Clarus!
Clarus Therapeutics to Present at the Oppenheimer 32nd Annual Healthcare Conference https://t.co/2dSQK3KzXb

[Vicky Cory @VCory]

Clarus Announces Strategic Partnerships for JATENZO® (testosterone undecanoate) with Vault Health and AssistRx – Leaders in Providing Healthcare Services to Patients https://t.co/Hn9NY0yIXS

[Vicky Cory @VCory]

Clarus Announces Strategic Partnerships for JATENZO® (testosterone undecanoate) with Vault Health and AssistRx – Leaders in Providing Healthcare Services to Patients https://t.co/Hn9NY0hFVS

[Blue Valley Schools @bvschools]

SCHOOLS CLOSED - Due to inclement weather all schools are closed Wednesday, February 21.

[Clarus Therapeutics @Clarus_Thera]

We are excited that Dr. Zhanna Jumadilova has joined Clarus as Chief Clinical Development Officer! Read more: https://t.co/MyqQusU1BJ #ClarusThera #CRXT #welcometotheteam